Literature DB >> 30387846

Parkin deficiency elevates hepatic ischemia/reperfusion injury accompanying decreased mitochondrial autophagy, increased apoptosis, impaired DNA damage repair and altered cell cycle distribution.

Xiao-Jie Ning1, Xiong Yan1, Yan-Feng Wang1, Ren Wang1, Xiao-Li Fan1, Zi-Biao Zhong1, Qi-Fa Ye1.   

Abstract

Hepatic ischemia/reperfusion injury (HIRI) serves a causative role in postoperative hepatocyte death; however, the mechanisms underlying HIRI remain unclear. Mitochondrial autophagy, with apoptosis, cell cycle distribution and DNA damage repair, may be regarded as a regulatory factor post‑HIRI. Parkin, a novel ubiquitin ligase, has been reported to increase mitochondrial autophagy and decrease apoptosis. However, the association between Parkin, mitochondrial autophagy and other regulatory factors in HIRI is unclear. In the present study, the effects of Parkin on HIRI were investigated, using hepatocytes and livers from male Sprague Dawley rats subjected to simulated in vivo HIRI. The results of the present study demonstrated that Parkin expression and mitochondrial autophagy were upregulated post‑HIRI, leading to decreased hepatocyte death. Parkin knockdown suppresses the level of mitochondrial autophagy and promotes hepatocyte apoptosis by suppressing apoptosis regulator Bcl‑2 function post‑HIRI. In addition, Parkin deficiency alters cell cycle distribution and impairs DNA damage repair post‑HIRI. In conclusion, Parkin facilitates mitochondrial autophagy and DNA damage repair, inhibits apoptosis, and modulates the cell cycle, leading to increased hepatocyte survival, demonstrating that Parkin may act as a protective regulatory factor post HIRI.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30387846     DOI: 10.3892/mmr.2018.9606

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

Review 1.  Insight into Crosstalk Between Mitophagy and Apoptosis/Necroptosis: Mechanisms and Clinical Applications in Ischemic Stroke.

Authors:  Yan-di Yang; Zi-Xin Li; Xi-Min Hu; Hao Wan; Qi Zhang; Rui Xiao; Kun Xiong
Journal:  Curr Med Sci       Date:  2022-04-07

2.  Remote Ischemic Preconditioning Attenuates Hepatic Ischemia/Reperfusion Injury after Hemorrhagic Shock by Increasing Autophagy.

Authors:  Hao Zhou; Lin Li; Hao Sun; Hua Li; Yuxuan Wu; Xiaomin Zhang; Jinsong Zhang
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

Review 3.  Regulation of autophagy protects against liver injury in liver surgery-induced ischaemia/reperfusion.

Authors:  Chenxia Hu; Lingfei Zhao; Fen Zhang; Lanjuan Li
Journal:  J Cell Mol Med       Date:  2021-10-08       Impact factor: 5.310

Review 4.  New Insights Into the Role of Autophagy in Liver Surgery in the Setting of Metabolic Syndrome and Related Diseases.

Authors:  Ana Isabel Álvarez-Mercado; Carlos Rojano-Alfonso; Marc Micó-Carnero; Albert Caballeria-Casals; Carmen Peralta; Araní Casillas-Ramírez
Journal:  Front Cell Dev Biol       Date:  2021-06-01

Review 5.  Role and Mechanisms of Mitophagy in Liver Diseases.

Authors:  Xiaowen Ma; Tara McKeen; Jianhua Zhang; Wen-Xing Ding
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

6.  Inhibition of excessive mitophagy by N-acetyl-L-tryptophan confers hepatoprotection against Ischemia-Reperfusion injury in rats.

Authors:  Huiting Li; Yitong Pan; Hongjuan Wu; Shuna Yu; Jianxin Wang; Jie Zheng; Can Wang; Jianguo Li; Jiying Jiang
Journal:  PeerJ       Date:  2020-04-09       Impact factor: 2.984

Review 7.  Mitophagy in the Pathogenesis of Liver Diseases.

Authors:  Po-Yuan Ke
Journal:  Cells       Date:  2020-03-30       Impact factor: 6.600

8.  Punicalin Alleviates OGD/R-Triggered Cell Injury via TGF-β-Mediated Oxidative Stress and Cell Cycle in Neuroblastoma Cells SH-SY5Y.

Authors:  Tiansong Yang; Qingyong Wang; Yuanyuan Qu; Yan Liu; Chuwen Feng; Yulin Wang; Weibo Sun; Zhongren Sun; Yulan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-12       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.